From: Revised French guidelines for the diagnosis and management of migraine in adults and children
Active component | Dosage (per day) | Side-effects | Contraindications |
---|---|---|---|
Propranolol | 40-240Â mg | Frequent: asthenia, poor tolerance to effort | Asthma, heart failure, atrio-ventricular block, bradycardia |
Metoprolol | 100-200Â mg | ||
Timolol (without MA) | 10-20Â mg | ||
Atenolol (without MA) | 100Â mg | Rare: insomnia, nightmares, impotence, depression | NB: possibility of aggravation of migraines with aura |
Nadolol (without MA) | 80-240Â mg | ||
Nebivolol (without MA) | 5Â mg | ||
Oxetorone | 60-180 mg (1–3 tablets) as one dose in the evening | Frequent: somnolence |  |
Rare: diarrhoea necessitating discontinuation of treatment | |||
Amitriptyline | 10-50Â mg in the evening | Dry mouth, somnolence | Glaucoma, prostatic adenoma |
Weight gain | |||
Pizotifen | 3 tablets per day at progressive doses | Sedation | Glaucoma, uredo-prostatic problems |
Weight gain | |||
Rare: digestive problems, dizziness, muscular pain, asthenia | |||
Topiramate | 50-100Â mg | Paresthesia | Hypersensitivity to topiramate |
Weight loss | Pregnancy | ||
Cognitive effects (word-finding difficulties) | Â | ||
Rare: renal calculi, acute myopia associated with secondary angle closure glaucoma | |||
Sodium valproate (without MA) | 500-1000Â mg | Nausea, weight gain, somnolence, trembling, alopecia, liver attack | Liver diseases |
Pregnancy | |||
Methysergide | 2-6 mg (1–3 tablets) Necessary to stop treatment for 1 month every 6 months | Frequent: nausea, dizziness, insomnia | Hypertension, heart failure, arteriopathologies, gastric ulcer, liver and kidney failure, association with triptans |
Rare: retroperitoneal fibrosis | |||
Flunarizine | 10Â mg (1 tablet in the evening). Not for more than 6 consecutive months | Frequent: somnolence, weight gain | Depressive syndrome, extra-pyramidal syndrome |
Rare: depression, extrapyramidal syndrome | |||
Gabapentin (without MA) | 1200-2400Â mg | Nausea, vomiting, convulsions, somnolence, ataxia, dizziness | Hypersensitivity to gabapentin |
Dihydroergotamine | 10Â mg | Nausea | Association with triptans |
Indoramin | 50 mg | Somnolence, nasal congestion, dry mouth, ejaculation problems | Hypersensitivity to one of the components of the drug product, Parkinson’s disease, severe heart, liver and kidney failure |
Candesartan (without MA) | 8-16Â mg | Arterial hypotension, dizziness | Hypersensitivity, severe liver and kidney failure |
2nd and 3rd trimester of pregnancy | |||
Venlafaxin (without MA) | 75-150Â mg | Nausea, dizziness, hypersudation, somnolence, nervousness, dry mouth | Hypersensitivity to venlafaxine, association with non-selective MAOI, congenital galactosaemia, breast feeding |